Embedded Files
Developing the world’s first biochemical diagnostic for early detection and prevention of emotional distress.
NeuroPath Biosciences is advancing a new era of precision mental health diagnostics.
Our research is focused on identifying biochemical markers that reflect early biological changes linked to emotional distress, the state that often precedes anxiety, depression, or self-harming behaviour.
By combining molecular science with digital assessment, we're creating the world’s first validated biochemical test for emotional distress, providing clinicians and caregivers an objective tool to detect risk early and intervene before symptoms escalate.
Our Approach
Our Approach
At NeuroPath, our approach bridges the gap between biology and mental health.
We integrate advanced metabolomics with data-driven analytics to uncover the biochemical fingerprints of emotional distress.
This work is designed to move mental health diagnostics from subjective reports to measurable, evidence-based insights enabling earlier support, better outcomes, and a more compassionate model of care.
Page updated
Google Sites
Report abuse